Quantum BioPharma Ltd.
QNTM
$3.89
-$0.16-3.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.16M | -26.18M | -28.51M | -27.02M | -20.88M |
| Total Depreciation and Amortization | 543.50K | 545.80K | 529.20K | 504.70K | 500.10K |
| Total Amortization of Deferred Charges | 1.49M | 1.49M | 1.49M | 1.49M | -- |
| Total Other Non-Cash Items | 25.08M | 13.92M | 9.02M | 7.33M | 614.90K |
| Change in Net Operating Assets | -1.60M | 1.99M | 8.70M | 7.19M | 10.60M |
| Cash from Operations | -5.64M | -8.24M | -8.77M | -10.51M | -9.16M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.50M | -1.95M | -1.06M | -4.93M | -2.83M |
| Cash from Investing | -3.50M | -1.95M | -1.06M | -4.93M | -2.83M |
| Total Debt Issued | 4.98M | 5.36M | 6.36M | 5.78M | 3.84M |
| Total Debt Repaid | -2.61M | -1.61M | -882.40K | -876.80K | -72.30K |
| Issuance of Common Stock | 5.88M | 529.70K | 1.68M | 8.72M | 10.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.72M | 1.82M | -- | -- | -- |
| Cash from Financing | 9.96M | 6.10M | 7.15M | 13.63M | 14.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 823.70K | -4.09M | -2.67M | -1.81M | 2.19M |